Evidence map›Paper›PMID 36482701›Full record

ArticleHuman vaccines & immunotherapeutics2022

Uptake of public health measures and vaccine acceptance during the COVID-19 pandemic in rural Zambia.

Catherine G Sutcliffe, Pamela Sinywimaanzi, Juliet Morales, Morris Sianyanda, Mathias Muleka, Katherine Z J Fenstermacher, Mwaka Monze, Richard E Rothman, Andrew Pekosz, Philip E Thuma and 1 more

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Catherine G SutcliffeDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Pamela SinywimaanziMacha Research Trust, Choma, Zambia.
Juliet MoralesDepartment of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Morris SianyandaMacha Research Trust, Choma, Zambia.
Mathias MulekaMacha Research Trust, Choma, Zambia.
Katherine Z J FenstermacherDepartment of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Mwaka MonzeVirology Laboratory, University Teaching Hospital, Lusaka, Zambia.
Richard E RothmanDepartment of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Andrew PekoszDepartment of Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Philip E ThumaMacha Research Trust, Choma, Zambia.
Edgar SimulunduMacha Research Trust, Choma, Zambia.

Funding

NIAID NIH HHS HHSN272201400007C
6 · The paper itself

Abstract

Vaccines are effective tools to prevent COVID-19-related morbidity. However, coverage is low throughout sub-Saharan Africa. Uptake of public health measures, perceptions of COVID-19 illness and vaccines, and intention to vaccinate were evaluated in 2021-2022 in rural Zambia. Adherence to public health measures, perceptions of COVID-19 risk and severity, and vaccine acceptance increased significantly over time, particularly in December 2021, coinciding with the fourth pandemic wave and relaunch of the national vaccine campaign. Vaccine acceptance was associated with perceptions of vaccine safety and effectiveness, but not disease severity. These findings highlight the importance of strong pandemic response and public communication for increased uptake of mitigatory measures, including vaccine acceptance.

Indexed as

COVID-19VaccinesHumansPandemicsPublic HealthVaccinationZambiaVaccinesCOVID-19perceptionspublic health measuressub-Saharan Africavaccines

Identifiers

PMID36482701
PMCPMC9762779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.